Pharmaceutical Technology
September 02, 2012
Issue PDF
36
9
Process Analytical Technology
September 02, 2012
Online Exclusive
36
9
Researchers have developed injectable, reformable, and spreadable hydrogels capable of delivering sustained release of the proteins they contain for up to six months.
September 02, 2012
In the Field
36
9
Q&A on GDUFA implementation with Aloka Srinivasan, PhD, a principal consultant with Parexel and former team leader in FDA's Office of Generic Drugs.
September 02, 2012
Special Features
36
9
A review of taints and odors in the pharmaceutical and consumer healthcare industries.
September 02, 2012
Position Papers
36
9
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.
September 02, 2012
Guest Editorial
36
9
PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.
September 02, 2012
Special Features
36
9
Advances in targeted drug delivery and customized release profiles are key industry goals.
September 02, 2012
Packaging Forum
36
9
Packaging and monitoring tools protect temperature-sensitive pharmaceuticals.
September 02, 2012
Viewpoint
36
9
Ties between the biotechnology industry and university research are crucial.
September 02, 2012
PharmTech Talk
36
9
The European Commission remains vigilant in monitoring potential pay-to-delay deals.
September 02, 2012
Agent-in Place
36
9
International trade can be great for business, but breaking border laws can put one in hot water.
September 02, 2012
Special Report
36
9
Industry experts share perspectives on analytical instrumentation, methods, and data analysis.
September 02, 2012
Pharma Ingredients
36
9
Industry and academia advance novel approaches for achieving enanioselectivity.
September 02, 2012
In the Spotlight
36
9
New product reviews for September 2012, featuring products for manufacturing.
September 02, 2012
Outsourcing Outlook
36
9
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
September 02, 2012
Troubleshooting
36
9
Identifying and classifying rouge can help to determine CAPA.
September 02, 2012
Inside USP
36
9
USP optimizes identification tests and impurities procedures.
September 02, 2012
Regulatory Watch
36
9
Import controls and risk strategies aim to promote quality and spur new drug development.
September 02, 2012
In the Field
36
9
Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.
September 02, 2012
Special Features
36
9
MIT survey results address product and site characteristics that statistically correlate with quality performance.
September 02, 2012
Peer-Reviewed Research
36
9
The authors investigate the tablet-coating process using a combination of different simulation techniques.